Fractional Laser Assisted Delivery of Sculptra® for the Treatment of Striae

Completed · Early Phase 1

Conditions studied: Striae Distensae

In brief

This study evaluates the efficacy of treatment of striae distensae using the combined modality of fractional laser and poly-L lactic acid (Sculptra).

Key facts

Study ID

NCT03858543

Run by

Henry Ford Health System

People needed

10

Starts

2019-07-15

Expected to finish

2021-01-31

Last updated by the study team

2021-08-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has bilateral striae alba
• Subject has stable body weight for at least 6 months with Fitzpatrick skin type 1-4

You may not qualify if…

• Subject has striae rubra
• Pregnant
• History of adverse effects to phototherapy
• Subject has single sided lesions
• Subject has immunosuppression
• Subject has radiation therapy to the study area
• Subject has topical or oral steroid use or chemotherapy within the last 6 months
• History of keloids or hypertrophic scar

Where it is running

• Henry Ford Health System — Detroit, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.